Clinical Trial Update: Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver

View source ↗

Summary

A clinical trial evaluating gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodules in cirrhotic liver has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Gadoxetic acid (gadoxetic acid)

Snippet

Sponsor: Jae Ho Byun | Conditions: Liver Cirrhosis, Carcinoma, Hepatocellular | Status: WITHDRAWN